Novo Nordisk Boss on Ozempic and Eating Disorder Criticism, Social Media Pressure

#Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO
Novo Nordisk has revolutionized the weight loss market with its blockbuster diabetes and obesity drugs, Ozempic and Wegovy. Celebrities have helped their popularity soar. Elon Musk, Sharon Osborne and Chelsea Handler have all publicly talked about taking Ozempic or Wegovy and they've had further backing from Oprah Winfrey. It’s a global phenomenon - reaching millions on platforms like TikTok. Speaking on Bloomberg’s Leaders With Lacqua, Novo Nordisk CEO Lars Fruergaard Jørgensen discusses the challenges the company has faced on social media and why he thinks trust needs to be placed in the doctors prescribing their drugs.
Watch the full interview: • The CEO Behind Ozempic...
#bloomberg #leaderswithlacqua #francinelacqua
--------
More on Bloomberg Television and Markets

Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: tinyurl.com/ys...
Visit www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.

Connect with Bloomberg Television on:
X: / bloombergtv
Facebook: / bloombergtelevision
Instagram: / bloombergtv

Connect with Bloomberg Business on:
X: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness
TikTok: www.tiktok.com...
Reddit: / bloomberg
LinkedIn: / bloomberg-news

More from Bloomberg:
Bloomberg Radio: / bloombergradio
Bloomberg Surveillance: / bsurveillance
Bloomberg Politics: / bpolitics
Bloomberg Originals: / bbgoriginals

Watch more on KZbin:
Bloomberg Technology: / @bloombergtechnology
Bloomberg Originals: / @business
Bloomberg Quicktake: / @bloombergquicktake
Bloomberg Espanol: / @bloomberg_espanol
Bloomberg Podcasts: / @bloombergpodcasts